Latest filing published 22 Jul 2019 for Fulcrum Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +37.0%Entry US$13.01 · Close at T+365 US$17.83
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
6 Dimensions Capital, L.P.: trading record in brief
All filings by 6 Dimensions Capital, L.P. on record concern Fulcrum Therapeutics, Inc. Altogether 2 filings, all relating to 22 July 2019.
Every open-market trade on record is a purchase: 1 purchase worth €1.7M, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The record was last updated on 22 July 2019 with a transaction in Fulcrum Therapeutics, Inc. The most recent open-market purchase was published on 22 July 2019, 2,667 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to 6 Dimensions Capital, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 441,071 sharesCommon StockSEC:0001104659-19-041307:0
- 118,750 shares@ US$16.00100.0% of flowCommon StockSEC:0001104659-19-041307:1Canonical exit: 20 Oct 2019 (T+90)
2 of 2 declarations
